Resolor 1 mg
Resolor 1 mg is a medicine authorised by Swissmedic under authorisation number 59304. The authorisation holder is Takeda Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 July 2010 and the authorisation is valid without a time limit. ATC code A06AX05 places the medicine in the group Drugs for constipation.
| Authorisation number | 59304 |
|---|---|
| Name | Resolor 1 mg |
| Full name | Resolor 1 mg, Filmtabletten |
| Authorisation holder | Takeda Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A06AX05 |
| First authorisation | 30 July 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Resolor 1 mg, Filmtabletten | B | 30 July 2010 |
| 2 | Resolor 2 mg, Filmtabletten | B | 30 July 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | A06AX05 | 04.08.11 | B |
| 2 | 28 | Tablette(n) | A06AX05 | 04.08.11 | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Resolor 1 mg authorised in Switzerland?
Yes. Resolor 1 mg is authorised by Swissmedic under authorisation number 59304, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Resolor 1 mg have?
Resolor 1 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Resolor 1 mg?
The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.